Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil for preventing relapse in autoimmune encephalitis
ChiCTR2100044362Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mycophenolate mofetil in Autoimmune Encephalitis (AE) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: cognitive function and inflammatory factors. Started Mar 2021; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
Autoimmune Encephalitis (AE)
Beyond the preview
Go deeper on ChiCTR2100044362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044362.